BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 17130541)

  • 1. MHC-linked susceptibility to type 1 diabetes in the NOD mouse: further localization of Idd16 by subcongenic analysis.
    Fujisawa T; Ikegami H; Noso S; Yamaji K; Nojima K; Babaya N; Itoi-Babaya M; Hiromine Y; Kobayashi M; Makino S; Ogihara T
    Ann N Y Acad Sci; 2006 Oct; 1079():118-21. PubMed ID: 17130541
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Congenic mapping of the MHC-linked susceptibility to type 1 diabetes in the NOD mouse: at least two genes contribute to the Idd16 effect.
    Hiromine Y; Fujisawa T; Noso S; Babaya N; Kawabata Y; Ikegami H
    Ann N Y Acad Sci; 2008 Dec; 1150():90-2. PubMed ID: 19120274
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contribution of class III MHC to susceptibility to type 1 diabetes in the NOD mouse.
    Yamaji K; Ikegami H; Fujisawa T; Noso S; Nojima K; Babaya N; Itoi-Babaya M; Kobayashi M; Hiromine Y; Makino S; Ogihara T
    Ann N Y Acad Sci; 2006 Oct; 1079():114-7. PubMed ID: 17130540
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MHC-linked diabetogenic gene of the NOD mouse: molecular mapping of the 3' boundary of the diabetogenic region.
    Ikegami H; Kawaguchi Y; Ueda H; Fukuda M; Takakawa K; Fujioka Y; Fujisawa T; Uchida K; Ogihara T
    Biochem Biophys Res Commun; 1993 Apr; 192(2):677-82. PubMed ID: 8097912
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cutting edge: homologous recombination of the MHC class I K region defines new MHC-linked diabetogenic susceptibility gene(s) in nonobese diabetic mice.
    Hattori M; Yamato E; Itoh N; Senpuku H; Fujisawa T; Yoshino M; Fukuda M; Matsumoto E; Toyonaga T; Nakagawa I; Petruzzelli M; McMurray A; Weiner H; Sagai T; Moriwaki K; Shiroishi T; Maron R; Lund T
    J Immunol; 1999 Aug; 163(4):1721-4. PubMed ID: 10438898
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Idd1 and Idd3 are necessary but not sufficient for development of type 1 diabetes in NOD mouse.
    Ikegami H; Fujisawa T; Sakamoto T; Makino S; Ogihara T
    Diabetes Res Clin Pract; 2004 Dec; 66 Suppl 1():S85-90. PubMed ID: 15563987
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Allelic variation in class I K gene as candidate for a second component of MHC-linked susceptibility to type 1 diabetes in non-obese diabetic mice.
    Inoue K; Ikegami H; Fujisawa T; Noso S; Nojima K; Babaya N; Itoi-Babaya M; Makimo S; Ogihara T
    Diabetologia; 2004 Apr; 47(4):739-47. PubMed ID: 15298352
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Congenic mapping and candidate sequencing of susceptibility genes for Type 1 diabetes in the NOD mouse.
    Ikegami H; Fujisawa T; Makino S; Ogihara T
    Ann N Y Acad Sci; 2003 Nov; 1005():196-204. PubMed ID: 14679059
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dissimilar background genes control susceptibility to autoimmune disease in the context of different MHC haplotypes: NOD.H-2(s) congenic mice are relatively resistant to both experimental autoimmune encephalomyelitis and type I diabetes.
    Greve B; Reddy J; Waldner HP; Sobel RA; Kuchroo VK
    Eur J Immunol; 2004 Jul; 34(7):1828-38. PubMed ID: 15214031
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Major histocompatibility complex-linked diabetes susceptibility in NOD/Lt mice: subcongenic analysis localizes a component of Idd16 at the H2-D end of the diabetogenic H2(g7) complex.
    Pomerleau DP; Bagley RJ; Serreze DV; Mathews CE; Leiter EH
    Diabetes; 2005 May; 54(5):1603-6. PubMed ID: 15855353
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of a new susceptibility locus for insulin-dependent diabetes mellitus by ancestral haplotype congenic mapping.
    Ikegami H; Makino S; Yamato E; Kawaguchi Y; Ueda H; Sakamoto T; Takekawa K; Ogihara T
    J Clin Invest; 1995 Oct; 96(4):1936-42. PubMed ID: 7560085
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence on spontaneous tissue inflammation by the major histocompatibility complex region in the nonobese diabetic mouse.
    Lindqvist AK; Nakken B; Sundler M; Kjellén P; Jonsson R; Holmdahl R; Skarstein K
    Scand J Immunol; 2005 Feb; 61(2):119-27. PubMed ID: 15683448
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sequence analysis of Tnf as a candidate for Idd16.
    Babaya N; Ikegami H; Fujisawa T; Ueda H; Nojima K; Itoi-Babaya M; Yamada K; Kawaguchi Y; Yamato E; Makino S; Ogihara T
    Autoimmunity; 2002 Feb; 35(1):63-6. PubMed ID: 11908709
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An interval tightly linked to but distinct from the H2 complex controls both overt diabetes (Idd16) and chronic experimental autoimmune thyroiditis (Ceat1) in nonobese diabetic mice.
    Boulard O; Damotte D; Deruytter N; Fluteau G; Carnaud C; Garchon HJ
    Diabetes; 2002 Jul; 51(7):2141-7. PubMed ID: 12086944
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of X- and Y-box deletions on the development of diabetes in H-2Ealpha-chain transgenic nonobese diabetic mice.
    O'Shea H; Yousaf N; Altmann D; Fehervari Z; Tonks P; Hetherington C; Harach S; Bland C; Cooke A; Lund T
    Scand J Immunol; 2006 Jan; 63(1):17-25. PubMed ID: 16398697
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Current studies on the identification of susceptibility genes for IDDM in NOD mice].
    Miyazaki J; Ishii M; Tashiro F
    Nihon Rinsho; 1994 Oct; 52(10):2772-7. PubMed ID: 7983813
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic mapping of a susceptibility locus for insulin-dependent diabetes mellitus on chromosome 11q.
    Hashimoto L; Habita C; Beressi JP; Delepine M; Besse C; Cambon-Thomsen A; Deschamps I; Rotter JI; Djoulah S; James MR
    Nature; 1994 Sep; 371(6493):161-4. PubMed ID: 8072544
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic control of autoimmune diabetes in the NOD mouse.
    Wicker LS; Todd JA; Peterson LB
    Annu Rev Immunol; 1995; 13():179-200. PubMed ID: 7612220
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cellular expression requirements for inhibition of type 1 diabetes by a dominantly protective major histocompatibility complex haplotype.
    Chen YG; Silveira PA; Osborne MA; Chapman HD; Serreze DV
    Diabetes; 2007 Feb; 56(2):424-30. PubMed ID: 17259387
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Subcongenic analysis of the Idd13 locus in NOD/Lt mice: evidence for several susceptibility genes including a possible diabetogenic role for beta 2-microglobulin.
    Serreze DV; Bridgett M; Chapman HD; Chen E; Richard SD; Leiter EH
    J Immunol; 1998 Feb; 160(3):1472-8. PubMed ID: 9570569
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.